drugset / Trial / NCT03726866

A Study to Investigate Drug-Drug Interaction Between D326, D337 and CKD-828 in Healthy Subjects

NCT03726866

Phase 1 Unknown 30 enrolled Chong Kun Dang Pharmaceutical
RandomizedCrossoverOpen-labelTreatment

Summary

To evaluate pharmacokinetic properties and drug interactions between D326 and D337 co-administered groups, the CKD-828 alone and the total co-administered groups.

Timeline

Start
2018-08-31
Primary completion
2019-01-15
Completion
2019-01-15

Drugs

EvaluationDrugModalityDoseRoute
Subject CKD-828 Unknown
Subject D326 Unknown
Subject D337 Unknown